These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

383 related items for PubMed ID: 21918792

  • 1. Efficacy of fluconazole and nystatin in the treatment of vaginal Candida species.
    Martins HP, da Silva MC, Paiva LC, Svidzinski TI, Consolaro ME.
    Acta Derm Venereol; 2012 Jan; 92(1):78-82. PubMed ID: 21918792
    [Abstract] [Full Text] [Related]

  • 2. Prevalence of Candida glabrata and its response to boric acid vaginal suppositories in comparison with oral fluconazole in patients with diabetes and vulvovaginal candidiasis.
    Ray D, Goswami R, Banerjee U, Dadhwal V, Goswami D, Mandal P, Sreenivas V, Kochupillai N.
    Diabetes Care; 2007 Feb; 30(2):312-7. PubMed ID: 17259500
    [Abstract] [Full Text] [Related]

  • 3. In vitro antifungal sensitivity of fluconazole, clotrimazole and nystatin against vaginal candidiasis in females of childbearing age.
    Khan F, Baqai R.
    J Ayub Med Coll Abbottabad; 2010 Feb; 22(4):197-200. PubMed ID: 22455297
    [Abstract] [Full Text] [Related]

  • 4. In vitro fluconazole and nystatin susceptibility and clinical outcome in complicated vulvovaginal candidosis.
    Fan SR, Liu XP.
    Mycoses; 2011 Nov; 54(6):501-5. PubMed ID: 20406393
    [Abstract] [Full Text] [Related]

  • 5. Vaginal nystatin versus oral fluconazole for the treatment for recurrent vulvovaginal candidiasis.
    Fan S, Liu X, Wu C, Xu L, Li J.
    Mycopathologia; 2015 Feb; 179(1-2):95-101. PubMed ID: 25416649
    [Abstract] [Full Text] [Related]

  • 6. [Vaginal candidiasis: etiology and sensitivity profile to antifungal agents in clinical use].
    Saporiti AM, Gómez D, Levalle S, Galeano M, Davel G, Vivot W, Rodero L.
    Rev Argent Microbiol; 2001 Feb; 33(4):217-22. PubMed ID: 11833253
    [Abstract] [Full Text] [Related]

  • 7. [Treatment of recurrent vulvovaginal candidosis with mycosyst (fluconazole)].
    Pekhlivanov B, Amaliev I, Ivancheva Kh, Zisova L.
    Akush Ginekol (Sofiia); 2005 Feb; 44 Suppl 2():25-7. PubMed ID: 16028400
    [Abstract] [Full Text] [Related]

  • 8. Guideline: vulvovaginal candidosis (AWMF 015/072), S2k (excluding chronic mucocutaneous candidosis).
    Mendling W, Brasch J, Cornely OA, Effendy I, Friese K, Ginter-Hanselmayer G, Hof H, Mayser P, Mylonas I, Ruhnke M, Schaller M, Weissenbacher ER.
    Mycoses; 2015 Mar; 58 Suppl 1():1-15. PubMed ID: 25711406
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Molecular typing and in vitro fluconazole susceptibility of Candida species isolated from diabetic and nondiabetic women with vulvovaginal candidiasis in India.
    Lattif AA, Mukhopadhyay G, Banerjee U, Goswami R, Prasad R.
    J Microbiol Immunol Infect; 2011 Jun; 44(3):166-71. PubMed ID: 21524609
    [Abstract] [Full Text] [Related]

  • 11. [Comparative study of itraconazole and fluconazole therapy in vaginal candidosis].
    Vacheva-Dobrevski R, Kovachev S, Nacheva A, Stoev S, Vasilev N.
    Akush Ginekol (Sofiia); 2004 Jun; 43(1):20-3. PubMed ID: 15168649
    [Abstract] [Full Text] [Related]

  • 12. [INVESTIGATION ON ANTIFUNGAL SUSCEPTIBILITY OF CANDIDA YEASTS IN PREGNANT PATIENTS WITH CONFIRMED VULVOVAGINAL CANDIDIASIS AND THEIR NEWBORNS.].
    Chokoeva A, Kouzmanov A, Ivanova Z, Zisova L, Amalie G, Petleshkova P, Miteva-Katrandzhieva T, Krasteva M, Uchikova E.
    Akush Ginekol (Sofiia); 2016 Jun; 55(4):20-29. PubMed ID: 29370489
    [Abstract] [Full Text] [Related]

  • 13. Guideline vulvovaginal candidosis (2010) of the German Society for Gynecology and Obstetrics, the Working Group for Infections and Infectimmunology in Gynecology and Obstetrics, the German Society of Dermatology, the Board of German Dermatologists and the German Speaking Mycological Society.
    Mendling W, Brasch J, German Society for Gynecology and Obstetrics, Working Group for Infections and Infectimmunology in Gynecology and Obstetrics, German Society of Dermatology, the Board of German Dermatologists, German Speaking Mycological Society.
    Mycoses; 2012 Jul; 55 Suppl 3():1-13. PubMed ID: 22519657
    [Abstract] [Full Text] [Related]

  • 14. Evolution of vaginal Candida species recovered from human immunodeficiency virus-infected women receiving fluconazole prophylaxis: the emergence of Candida glabrata? Terry Beirn Community Programs for Clinical Research in AIDS (CPCRA).
    Vazquez JA, Sobel JD, Peng G, Steele-Moore L, Schuman P, Holloway W, Neaton JD.
    Clin Infect Dis; 1999 May; 28(5):1025-31. PubMed ID: 10452629
    [Abstract] [Full Text] [Related]

  • 15. Vulvovaginal candidiasis in a Flemish patient population.
    De Vos MM, Cuenca-Estrella M, Boekhout T, Theelen B, Matthijs N, Bauters T, Nailis H, Dhont MA, Rodriguez-Tudela JL, Nelis HJ.
    Clin Microbiol Infect; 2005 Dec; 11(12):1005-11. PubMed ID: 16307555
    [Abstract] [Full Text] [Related]

  • 16. [Prevalence of Candida albicans and Candida non-albicans in clinical samples during 1999-2001].
    Mujica MT, Finquelievich JL, Jewtuchowicz V, Iovannitti CA.
    Rev Argent Microbiol; 2004 Dec; 36(3):107-12. PubMed ID: 15559191
    [Abstract] [Full Text] [Related]

  • 17. Biofilms Formed by Isolates from Recurrent Vulvovaginal Candidiasis Patients Are Heterogeneous and Insensitive to Fluconazole.
    Sherry L, Kean R, McKloud E, O'Donnell LE, Metcalfe R, Jones BL, Ramage G.
    Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28696240
    [Abstract] [Full Text] [Related]

  • 18. Prevalence, species distribution and antifungal sensitivity of vaginal yeasts in infertile women.
    Verghese S, Padmaja P, Asha M, Elizabeth SJ, Anitha A, Kundavi KM, Jayanthi N, Varma T.
    Indian J Pathol Microbiol; 2001 Jul; 44(3):313-4. PubMed ID: 12024920
    [Abstract] [Full Text] [Related]

  • 19. [Identification and in vitro antifungal susceptibility of vaginal Candida spp. isolates to fluconazole, clotrimazole and nystatin].
    Diaz MC, Camponovo R, Araya I, Cerda A, Santander MP, Carrillo-Muñoz AJ.
    Rev Esp Quimioter; 2016 Jun; 29(3):151-4. PubMed ID: 27167765
    [Abstract] [Full Text] [Related]

  • 20. Prevalence of Candida albicans and non-albicans isolates from vaginal secretions: comparative evaluation of colonization, vaginal candidiasis and recurrent vaginal candidiasis in diabetic and non-diabetic women.
    Gunther LS, Martins HP, Gimenes F, Abreu AL, Consolaro ME, Svidzinski TI.
    Sao Paulo Med J; 2014 Jun; 132(2):116-20. PubMed ID: 24714993
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.